Clinical effectiveness of branded versus generic piperacillin-tazobactam for treating severe community-acquired pneumonia

Cheng-Yi Wang,Chia-Hung Chen,Chih-Yen Tu,Wei-Chih Chen,Li-Kuo Kuo,Yao-Tung Wang,Pin-Kuei Fu,Shih-Chi Ku,Wen-Feng Fang,Chin-Ming Chen,Chih-Cheng Lai

Journal of Infection and Public Health（2022）

引用 0|浏览4

暂无评分

摘要

Based on the findings of the present study using indirect comparison, the clinical effectiveness of generic piperacillin-tazobactam for treating patients with severe CAP might not be as good as that of brand-name products.

查看译文

关键词

CAP,HAP,VAP

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要